Post-approval studies (Phase 4)UnknownNCT00838019What this trial is testingIntrabone Cord Blood TransplantationWho this might be right forHematological Malignancies Hospital Clinic of Barcelona 10
Not applicableLooking for participantsNCT06509945What this trial is testingAllo-PBSCT as the First-line Treatment for Patients With the High-risk PTCLWho this might be right forPeripheral T Cell Lymphoma Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Testing effectiveness (Phase 2)Looking for participantsNCT05027945What this trial is testingA Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) SyndromeWho this might be right forImmunodeficiencyHematopoietic Stem Cell Transplantation National Cancer Institute (NCI) 54
Not applicableUnknownNCT01864395What this trial is testingClinical and Chemical Outcomes Following Cardiac Surgery: The Post-Operative Effects of MUFWho this might be right forCoronary Artery DiseaseAnemia University of Saskatchewan 90
Early research (Phase 1)Study completedNCT00092937What this trial is testingUse of Busulfan as Conditioning Agent for a Second Stem Cell TransplantWho this might be right forGranulomatous DiseaseChronic National Institute of Allergy and Infectious Diseases (NIAID) 2
Testing effectiveness (Phase 2)Study completedNCT00721045What this trial is testingA Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart FailureWho this might be right forHeart Failure Mesoblast, Ltd. 60
Testing effectiveness (Phase 2)UnknownNCT01423175What this trial is testingClAraC or FLAMSA Followed by Stem Cell Transplantation to Treat High Risk AML or Advanced MDSWho this might be right forAcute Myeloid LeukemiaMDS Hannover Medical School 60
Testing effectiveness (Phase 2)Looking for participantsNCT06345495What this trial is testingHigh Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With SplenomegalyWho this might be right forSplenomegalyMyelofibrosis M.D. Anderson Cancer Center 30
Not applicableStudy completedNCT01904175What this trial is testingRegistry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell TransplantWho this might be right forHodgkin's DiseaseNon Hodgkin's LymphomaMyeloma+2 more Duke University 48
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Not Yet RecruitingNCT07254793What this trial is testingProphylactic and Therapeutic DLI-X for Leukemia Relapse After HCTWho this might be right forAcute Lymphoid LeukemiaAcute Myeloid LeukemiaAcute Undifferentiated Leukemia (AUL)+3 more University of Arizona 94
Early research (Phase 1)Ended earlyNCT06128044What this trial is testingCRISPR-Edited Allogeneic Anti-CLL-1 CAR-T Cell Therapy in Patients With Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia Refractory Caribou Biosciences, Inc. 12
Large-scale testing (Phase 3)UnknownNCT04000698What this trial is testingPersonalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Acute LeukemiasWho this might be right forRefractory Acute Myeloid LeukemiaRefractory Acute Lymphoblastic Leukemia Federal Research Institute of Pediatric Hematology, Oncology and Immunology 25
Not applicableUnknownNCT01252784What this trial is testingReduced-intensity Conditioning Allogeneic Hematopoietic Cell TransplantationWho this might be right forMyelodysplastic Syndrome Cooperative Study Group A for Hematology 20
Early research (Phase 1)Study completedNCT01173016What this trial is testingAdministration of IV Laronidase Post Bone Marrow Transplant in HurlerWho this might be right forHurler Syndrome Masonic Cancer Center, University of Minnesota 11
Early research (Phase 1)Temporarily pausedNCT05993611What this trial is testingAllogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell TransplantationWho this might be right forChronic Graft Versus Host DiseaseHematologic and Lymphocytic DisorderSteroid Refractory Graft Versus Host Disease City of Hope Medical Center 27
Testing effectiveness (Phase 2)Ended earlyNCT00924001What this trial is testingChemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic MelanomaWho this might be right forMelanomaMalignant MelanomaMelanoma, Experimental National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Study completedNCT00116467What this trial is testingVaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous LeukemiaWho this might be right forAcute Myelogenous Leukemia Cell Genesys 55
Testing effectiveness (Phase 2)Study completedNCT03678493What this trial is testingFMT in Patients With AML Allo HSCT in RecipientsWho this might be right forAcute Myeloid LeukemiaAllogeneic Hematopoietic Cell Transplantation Masonic Cancer Center, University of Minnesota 100
Testing effectiveness (Phase 2)Study completedNCT01839916What this trial is testingDonor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more University of Chicago 77